NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,144,443 | -24.4% | 1,048,098 | +0.0% | 0.01% | -28.6% |
Q2 2023 | $26,636,246 | -29.9% | 1,047,846 | -0.3% | 0.01% | -36.4% |
Q1 2023 | $37,986,745 | -8.0% | 1,050,809 | +0.8% | 0.01% | -8.3% |
Q4 2022 | $41,270,169 | -15.2% | 1,042,176 | -0.2% | 0.01% | -25.0% |
Q3 2022 | $48,659,000 | +6.4% | 1,044,181 | +0.1% | 0.02% | +14.3% |
Q2 2022 | $45,713,000 | -39.3% | 1,042,954 | +0.2% | 0.01% | -26.3% |
Q1 2022 | $75,293,000 | -10.2% | 1,040,973 | +0.6% | 0.02% | -5.0% |
Q4 2021 | $83,879,000 | -48.9% | 1,034,650 | -26.6% | 0.02% | -52.4% |
Q3 2021 | $164,123,000 | -30.2% | 1,410,242 | -0.6% | 0.04% | -27.6% |
Q2 2021 | $235,272,000 | +19.5% | 1,419,094 | +0.6% | 0.06% | +9.4% |
Q1 2021 | $196,873,000 | -22.1% | 1,411,275 | -3.3% | 0.05% | -28.4% |
Q4 2020 | $252,566,000 | +24.7% | 1,459,074 | +0.4% | 0.07% | +8.8% |
Q3 2020 | $202,461,000 | +15.6% | 1,453,415 | -0.9% | 0.07% | +7.9% |
Q2 2020 | $175,182,000 | +23.5% | 1,466,330 | +3.3% | 0.06% | +5.0% |
Q1 2020 | $141,891,000 | -17.3% | 1,419,187 | -2.8% | 0.06% | +13.2% |
Q4 2019 | $171,547,000 | +0.5% | 1,459,483 | -26.5% | 0.05% | +17.8% |
Q3 2019 | $170,625,000 | +33.5% | 1,984,709 | +0.7% | 0.04% | +36.4% |
Q2 2019 | $127,778,000 | +331.7% | 1,970,969 | +316.2% | 0.03% | +230.0% |
Q1 2019 | $29,600,000 | +61.8% | 473,514 | +0.7% | 0.01% | +42.9% |
Q4 2018 | $18,290,000 | -30.8% | 470,281 | +1.4% | 0.01% | -12.5% |
Q3 2018 | $26,432,000 | -53.2% | 463,718 | -34.4% | 0.01% | -57.9% |
Q2 2018 | $56,434,000 | -8.8% | 706,750 | -1.0% | 0.02% | -17.4% |
Q1 2018 | $61,874,000 | +27.2% | 713,903 | +1.3% | 0.02% | +27.8% |
Q4 2017 | $48,639,000 | -35.8% | 704,512 | -15.5% | 0.02% | -35.7% |
Q3 2017 | $75,794,000 | +21.4% | 833,987 | -0.6% | 0.03% | +47.4% |
Q2 2017 | $62,423,000 | -20.0% | 838,672 | +0.8% | 0.02% | -26.9% |
Q1 2017 | $77,981,000 | +23.6% | 832,234 | -4.1% | 0.03% | +23.8% |
Q4 2016 | $63,078,000 | +95.4% | 868,131 | +180.8% | 0.02% | +90.9% |
Q3 2016 | $32,277,000 | +57537.5% | 309,207 | +29320.3% | 0.01% | – |
Q2 2015 | $56,000 | – | 1,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |